// you’re reading...

General Biotechnology

Biotech plans: Boon or fantasy?

By Yali ⋅ October 20, 2003 ⋅ Email This Post Email This Post ⋅ Print This Post Print This Post ⋅ Post a comment

Biotech plans: Boon or fantasy?
Having mapped hormones, synthesized molecules and discovered new cell receptors, the Scripps Research Institute wants to embark on one of its biggest cloning experiments: converting the Sunshine State into biotech beach by using $510 million from taxpayers.

Print This Post

Discussion

No comments for “Biotech plans: Boon or fantasy?”

Post a comment

Building Biotechnology - Starting, Managing, and Understanding Biotechnology Companies   The Business of Biotechnology - Profit From the Growing Influence of Biotechnology
Best Practices in Biotechnology Business Development Best Practices in Biotechnology Education
Journal of Commercial Biotechnology 
DrugPatentWatch.com